
Chestify AI Labs is a healthcare technology company that offers Chestify AI, a tele-AI radiology platform connecting radiologists and medical practitioners with healthcare facilities for biomedical image reporting. The platform features an AI DICOM-enabled viewer for faster annotations and report writing, optimizing workflow and enhancing diagnostic accuracy. It supports various medical imaging types including CT, X-Ray, Ultrasound, and Mammography. The company targets regions with limited radiology infrastructure, particularly sub-Saharan Africa and the Caribbean, addressing the shortage of radiologists and diagnostic equipment. Chestify AI Labs provides a comprehensive solution including PACS Server, RIS System, FDA-cleared DICOM viewer, payment and billing systems, AI second opinion, image archive, and data analytics. The platform enables healthcare facilities to be set up within 24 hours, facilitating rapid report turnaround times of 12 hours or less, thus improving patient care and diagnostic efficiency in underserved markets.

Chestify AI Labs is a healthcare technology company that offers Chestify AI, a tele-AI radiology platform connecting radiologists and medical practitioners with healthcare facilities for biomedical image reporting. The platform features an AI DICOM-enabled viewer for faster annotations and report writing, optimizing workflow and enhancing diagnostic accuracy. It supports various medical imaging types including CT, X-Ray, Ultrasound, and Mammography. The company targets regions with limited radiology infrastructure, particularly sub-Saharan Africa and the Caribbean, addressing the shortage of radiologists and diagnostic equipment. Chestify AI Labs provides a comprehensive solution including PACS Server, RIS System, FDA-cleared DICOM viewer, payment and billing systems, AI second opinion, image archive, and data analytics. The platform enables healthcare facilities to be set up within 24 hours, facilitating rapid report turnaround times of 12 hours or less, thus improving patient care and diagnostic efficiency in underserved markets.